Bilypsa 4 Tablet is used to manage diabetic dyslipidaemia (raised triglycerides and abnormal cholesterol) in adults with type 2 diabetes when statins alone are not sufficient, and may also be used in non-alcoholic steatohepatitis (NASH) associated with metabolic disorders.
It contains saroglitazar (4 mg), a dual PPAR alpha/gamma agonist. Take it as prescribed, under specialist supervision. Regular monitoring of liver function is important during treatment.
A diet low in saturated fat and simple sugars, regular activity and keeping to all monitoring appointments support better metabolic health alongside this medicine.
Tell your doctor about any liver problems, heart failure or history of bladder cancer before starting. Report any signs of liver problems such as nausea, yellowing of skin or eyes, or dark urine.

























































